.png?width=200&height=48&name=Tissue-Cypher-White-RGB%20(1).png "Tissue-Cypher-White-RGB (1)"){kind=small}
DDW 2024 is the place to learn about TissueCypher and Barrett’s esophagus risk stratification
Data from three new TissueCypher studies will be presented at Digestive Disease Week 2024 in Washington, D.C.
If you’re planning to attend, book some time with our team to discuss how this innovative prognostic test can improve management of Barrett’s esophagus patients. The Castle Biosciences team will be at Booth 3737 near Product Theater 1.
Events featuring TissueCypher
DDW Product Theater 1
BEyond the diagnosis:
Personalized, precision medicine in the management of Barrett’s esophagus
Tues., May 21, 12-12:45 p.m. ET
Add to calendar (.ics)
DDW Product Theater 1
This multi-specialist panel discussion will highlight the benefits of identifying a patient's individualized risk of progression from Barrett's esophagus to HGD/EAC. Panelists will discuss the incorporation of TissueCypher results in directing the clinical management of BE patients, and how it can be more effective than relying on population-based progression risks tied to traditional clinicopathologic risk factors. Panelists will also discuss the cross-specialty coordination of care.
Emmanuel Gorospe, MD, MPH, FACP, FACG, FASGE
GI Medical Director, Castle Biosciences
Dan Lister, MD, FACS, FAFS
Surgeon and Director of the Arkansas Heartburn Treatment Center. Co-Founder and President Elect of the American Foregut Society
Farhan Quader, MD
Interventional Gastroenterologist, NorthShore University Hospital, Chicago
Sarah Enslin, PA-C
Division of Gastroenterology and Hepatology University of Rochester Medical Center Rochester, New York
AGA Research Forum
Advances in Barrett's Esophagus
Session Number: 3265
TissueCypher Presentation:
The tissue systems pathology test enables risk-aligned management for patients with Barrett’s esophagus (392)
Sun., May 19, 10-11:30 a.m. ET
Add to calendar (.ics)
146C - Walter E. Washington Convention Center
Lucas Duits, MD, PhD
Gastroenterologist, Amsterdam UMC
Sun., May 19, 12:30 - 1:30 p.m. ET
Add to calendar (.ics)
The tissue systems pathology test predicts risk of malignant progression in patients with Barrett's esophagus: a systematic review and meta-analysis
Su1267
The tissue systems pathology test provides clinically actionable risk-stratification in patients with Barrett’s esophagus: a multicenter U.S. clinical experience
A modern approach to the clinical management of patients with Barrett’s esophagus
Harshit Khara, MD
Geisinger Medical Center
Sat., May 18, 10:15-10:45 a.m. ET
Add to calendar (.ics)
Leveraging clinically-impactful risk stratification for patients with Barrett’s esophagus
John C. Lipham, MD
Keck Medicine of USC
Mon., May 20, 2:45-3:15 p.m. ET
Add to calendar (.ics)
Castle Biosciences will have Area Managers, Medical Science Liaisons, product specialists and others available to answer any question you may have.
Sun., May 19 - Tues., May 21